• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec8
JWCTAR201 IIT Research Data Released by Juno Therapeutics-B
09:42
Dec7
5 CAR-T Cell Therapy Products Included in the First Batch of Commercial Insurance Innovative Drug Catalog
03:17
Nov2
Yumeng Juno's CAR-T Cell Drug Aims for Inclusion in Commercial Insurance Innovative Drug Catalog
09:34
Oct21
JW Therapeutics Submits First-in-Human Phase I Data for Relmacabtagene Autoleucel
08:35
Oct9
JW Therapeutics' Relmacabtagene Ablamelical (Relma-Cel) Supplemental Application for Domestic Slow Virus Vector Approved for Filing by NMPA
09:00
Sep3
CICC Raises JUNO Therapeutics' Target Price to HKD 6.04
02:47

Schedules & Filings

Schedules
Filings
Aug27
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 58.2 M, Net Income -146.26 M, EPS -0.3519

Mar27
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 37.98 M, Net Income -186.36 M, EPS -0.4499

Aug28
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 46.64 M, Net Income -129.09 M, EPS -0.3124

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
02205
1.200
+73.91%
+0.510
02370
0.670
+57.65%
+0.245
00704
0.130
+52.94%
+0.045
01546
0.086
+45.76%
+0.027
02431
14.710
+31.22%
+3.500
08081
0.018
+28.57%
+0.004
09929
0.600
+20.00%
+0.100
01005
0.480
+20.00%
+0.080
08018
0.039
+18.18%
+0.006
08366
0.035
+16.67%
+0.005
View More